Ways2Capital Reviews : Torrent And Aurobindo Pharma Get Final USFDA Approval For gViagra

USFDA has approved Sildenafil Citrate generics of Torrent, Aurobindo and Hetero Labs. Sildenafil Citrate is sold under Viagra brand by Pfizer. The approval is for both the strengths i.e. 25mg and 50mg and Teva is already selling this drug.

The 25mg market was ~$30mn while 50mg market was ~$300mn so considering that there are only five generic players, this is good opportunity ($10-15mn per year) for the companies.

We are positive on Torrent and Aurobindo and expect the stocks to continue to trade with the positive bias.

Torrent Pharmaceuticals Ltd is currently trading at Rs1,433.55 up by Rs25.8 or 1.83% from its previous closing of Rs1,407.75 on the BSE.

Aurobindo Pharma Ltd is currently trading at Rs600.45 up by Rs5.95 or 1% from its previous closing of Rs594.50 on the BSE.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626191 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717
Share on Google Plus Share on Pinterest

About Bhoomi Desai